Profile data is unavailable for this security.
About the company
Kanabo Group plc is a United Kingdom-based patient-focused provider of digital health services and specialist medicines. The Company’s principal activities are the distribution and development of cannabis derived medical and wellness products. The Company operates through two segments: Primary case and Secondary case. Primary case segment is involved in the telepharma services provided by GPS. Secondary case segment is involved in the distribution and development of cannabis-derived medical and wellness products. The Company is focused on the distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for cannabidiol (CBD) consumers. It has conducted research and development (R&D) in order to develop cannabis extract formulas, medical-grade vaporizers and various non-smoking consumption solutions. Its clinical and validation activities, including safety and efficiency tests, are conducted in Israel.
- Revenue in GBP (TTM)1.14m
- Net income in GBP-8.18m
- Incorporated2016
- Employees17.00
- LocationKanabo Group PLCChurchill House, 137-139 Brent StreetLONDON NW4 4DJUnited KingdomGBR
- Websitehttps://www.kanabogroup.com/investors/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Saroja Pharma Industries India Ltd | 6.00m | 103.82k | 1.19m | 12.00 | 11.38 | 0.8922 | 10.43 | 0.1976 | 3.17 | 3.17 | 183.12 | 40.41 | -- | -- | -- | 61,135,500.00 | -- | 5.16 | -- | 11.56 | 6.85 | 10.01 | 1.73 | 2.05 | 1.19 | 2.00 | 0.3926 | -- | 32.11 | 25.76 | 17.75 | 45.07 | 157.98 | -- |
| Stemcell Holdings Inc | 7.38m | 2.29m | 1.21m | -- | -- | -- | 0.5008 | 0.1645 | 0.00008 | 0.00008 | 0.0003 | 0.0002 | 1.12 | -- | 5.20 | -- | 34.90 | -- | 68.19 | -- | 77.19 | -- | 31.04 | -- | -- | -- | 0.00 | -- | 85.10 | -- | 71.82 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.04m | -5.67m | 1.25m | 40.00 | -- | -- | -- | 0.6102 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 2.58 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| Biosenic SA | 0.00 | -4.15m | 1.31m | 3.00 | -- | -- | -- | -- | -0.0172 | -0.0172 | 0.00 | -0.0774 | 0.00 | -- | -- | 0.00 | -93.83 | -69.58 | -- | -144.27 | -- | -- | -- | -3,376.80 | -- | -3.46 | -- | -- | -- | -- | 83.43 | -- | -- | -- |
| Onconetix Inc | 904.57k | -37.58m | 1.40m | 5.00 | -- | 0.5643 | -- | 1.55 | -350.74 | -350.74 | 2.14 | 2.16 | 0.03 | 1.31 | 24.33 | 244,750.00 | -120.44 | -82.49 | -240.72 | -114.71 | 85.41 | -- | -4,015.56 | -4,434.98 | 0.0706 | -17.94 | 0.0453 | -- | 4,216.95 | -- | -57.44 | -- | 44.62 | -- |
| Kanabo Group PLC | 1.14m | -8.18m | 1.42m | 17.00 | -- | 0.2402 | -- | 1.25 | -0.013 | -0.013 | 0.0018 | 0.0094 | 0.1054 | 16.28 | 43.85 | 67,058.82 | -75.70 | -75.83 | -81.16 | -83.33 | 7.89 | -- | -718.33 | -1,267.35 | 2.72 | -63.43 | 0.0337 | -- | 48.42 | -- | -16.26 | -- | -- | -- |
| Bio Essence Corp | 418.13k | -118.60k | 1.53m | 2.00 | -- | -- | -- | 3.67 | -0.0042 | -0.0042 | 0.0149 | -0.0816 | 1.26 | -- | 16.06 | 282,835.00 | -35.64 | -40.94 | -- | -- | 69.28 | 38.36 | -28.36 | -134.00 | -- | -57.42 | -- | -- | -- | -17.08 | -286.98 | -- | -- | -- |
| Mono Pharmacare Ltd | 12.07m | 66.93k | 1.57m | 115.00 | 23.56 | 0.614 | 19.86 | 0.13 | 0.4605 | 0.4605 | 77.21 | 17.67 | 1.35 | 2.71 | 2.76 | 12,823,770.00 | 0.7704 | -- | 1.53 | -- | 8.63 | -- | 0.5716 | -- | 1.08 | 1.12 | 0.6376 | -- | 37.60 | -- | 26.52 | -- | -- | -- |
| Universe Pharmaceuticals Inc | 13.20m | -2.71m | 1.66m | 216.00 | -- | 0.0399 | -- | 0.1256 | -10.13 | -10.13 | 39.18 | 99.64 | 0.2602 | 5.88 | 1.38 | 82,679.35 | -5.35 | -5.40 | -7.08 | -7.09 | 35.28 | 43.33 | -20.56 | -9.65 | 3.90 | -17.46 | 0.1416 | -- | -22.44 | -10.27 | 57.92 | -- | 46.30 | -- |
